Bingtao Hao
- Cancer Research top 5%
- Molecular Biology top 5%
- RNA Research and Splicing 11
- RNA modifications and cancer 10
- Genomics and Chromatin Dynamics 8
- DNA Repair Mechanisms 6
- Congenital heart defects research 5
- Immunology top 10%
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 9
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
- Oncology top 10%
Bingtao Hao
68 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 316
- Molecular Biology 1.4k
- Immunology 354
- Pharmacology 145
- Oncology 383
Countries citing papers authored by Bingtao Hao
This map shows the geographic impact of Bingtao Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingtao Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingtao Hao more than expected).
Fields of papers citing papers by Bingtao Hao
This network shows the impact of papers produced by Bingtao Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingtao Hao. The network helps show where Bingtao Hao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bingtao Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 22 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 31 | |
| 12 | 2019 | 4 | |
| 13 | 2019 | 17 | |
| 14 | 2011 | 187 | |
| 15 | 2010 | 61 | |
| 16 | 2010 | 17 | |
| 17 | 2008 | 21 | |
| 18 | 2007 | 4 | |
| 19 | Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer | 2006 | 41 |
| 20 | 2006 | 91 |
About Bingtao Hao
Bingtao Hao is a scholar working on Immunology, Molecular Biology and Pharmacology, having authored 76 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA Research and Splicing (11 papers), RNA modifications and cancer (10 papers), Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (9 papers), Genomics and Chromatin Dynamics (8 papers), DNA Repair Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Congenital heart defects research (5 papers). The work is most often cited by research in Cancer Research (316 citations), Molecular Biology (1.4k citations) and Immunology (354 citations). Bingtao Hao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fuchu He, Dongxin Lin, Wen Tan, Xiaoping Miao, Michael S. Krangel, Haijian Wang, Gangqiao Zhou, Qingyi Wei, Yunping Zhu and Xiaoping Chen. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.